Hüseyin YILDIZ, Solmaz GÜNAL, Hale Yarkan UYSAL

Acil splenektomioperasyonu planlanan idyopatik trombositopenik purpuralı (İTP) olguda anestezik yaklaşım

Primer immün veya otoimmün trombositopenik purpura olarak da bilinen idyopatik trombositopenik purpura (İTP); trombosit sayısının azalması, kanama zamanının uzaması, deri ve mukozalarda yaygın kanama odakları ile karakterize otoimmün bir hastalıktır. İTP çocuklarda ve erişkinlerde görülen trombositopeni ve kanama komplikasyonlarının en sık nedenidir. Tedavide; glukokortikoidler, intravenöz immünglobulin, plazmaferez ve splenektomi uygulanmaktadır. Bu olgu sunumunda İTP tanısıyla acil splenektomi operasyonu planlanan hastada genel anestezi deneyimimiz sunulmuştur.

Anaesthetic management of a case of idiopathic thrombocytopenic purpura for emergency splenectomy

Idiopathic thrombocytopenic purpura (ITP), also known as primary immune or autoimmune thrombocytopenic purpura, is characterized by a decrease in platelet count, prolongation of bleeding time, and diffuse bleeding spots seen on the skin and mucosa. ITP is a common cause of thrombocytopenia and bleeding complications in children and adults. Glucokorticoids, intravenous immunglobulin, plasmapheresis, and splenectomy have been used for the treatment of ITP. In this case report, anaesthetic management for emergency splenectomy in a patient diagnosed with ITP is presented.

PDF

___

1. Andreoli TE, Bennett JC, Carpenter CJ, Plum F, Smith LH. Cecil Essentials of Medicine. Türkçesi. Tuzcu M (ed). Philadelphia: W.B. Saunders Company; 1995, 404-405.
2. Shuman M: Hemorrhagic disorders: abnormalities of platelet and vascular function. In Goldman L, Ausiello D: Cecil Textbook of Medicine. Philadelphia, Pennsylvania: Saunders; 2004, 22nd ed. P: 1060-1064
3. Diagnosis and treatment of idiopathic thrombocytopenic purpura: Recommendations of the American Society of Hematology. The American Society of Hematology ITP Practice Guideline Panel. Ann Intern Med 1997; 126: 319-326.
4. George JN, El-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1995; 331: 1207-11.
5. George JN, El-Harake MA, Aster RH. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: Beutler E, Lictman MA, Coller BS, Kipps TJ (eds). Williams Hematology. 5th ed. New York: McGraw-Hill; 1995: 1315-55.
6. Cortelazzo S, Finazzi G, Buelli M, et al. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991; 77: 31-33.
7. Handin RI: Disorders of hemostasis: disorders of the platelet and vessel wall. In Kasper, Braunwald, Fauci, et al.: Harrison’s Principal of Internal Medicine. McGraw-Hill; 2005, 16th ed. P: 673-680.
8. Portielje, JE, Westendorp, RG, Kluin-Nelemans, HC, Brand, A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001; 97: 2549.
9. Wu JM, Lai IR, Yuan RH, Yu SC. Laparascopic splenectomy for idiopathic thrombocytopenic purpura. Am J Surg 2004; 187: 720.
10. Sherke RR, Rao MS. Anaesthetic management of splenectomy in Evan’s syndrome during pregnancy with pregnancy induced hypertension. J Postgrad Med 2001; 47: 196-8.